Immuno-oncology is a new area of medicine that focuses on the development and delivery of therapies that improve the body’s intrinsic potential for generating an effective immune response against cancer. Although immuno-oncology is still in its infancy, immunotherapy has been yielding clinical results for some time, and the most recent agents entering the clinic look even more promising.
Immuno-oncology is a promising, emerging therapeutic approach to disease management in cancer. Research under way is aimed at understanding how the immune system itself can be powered to recognize and eliminate cancer cells. Although still in its early stages, immune-mediated therapies are showing the potential to dramatically improve outcomes for patients with certain types of cancer.